Elevai Labs Statistics
Total Valuation
Elevai Labs has a market cap or net worth of $10.81 million. The enterprise value is $10.04 million.
| Market Cap | 10.81M |
| Enterprise Value | 10.04M |
Important Dates
The next estimated earnings date is Tuesday, August 27, 2024, before market open.
| Earnings Date | Aug 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Elevai Labs has 18.89 million shares outstanding. The number of shares has increased by 78.52% in one year.
| Shares Outstanding | 18.89M |
| Shares Change (YoY) | +78.52% |
| Shares Change (QoQ) | +61.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.95 |
| Forward PS | n/a |
| PB Ratio | 4.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.57 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -113.24 |
Financial Efficiency
Return on equity (ROE) is -297.10% and return on invested capital (ROIC) is -172.68%.
| Return on Equity (ROE) | -297.10% |
| Return on Assets (ROA) | -145.00% |
| Return on Capital (ROIC) | -172.68% |
| Revenue Per Employee | $121,352 |
| Profits Per Employee | -$256,566 |
| Employee Count | 18 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 36.36 |
| Average Volume (20 Days) | 69,331 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Elevai Labs had revenue of $2.18 million and -$4.62 million in losses. Loss per share was -$0.37.
| Revenue | 2.18M |
| Gross Profit | 1.48M |
| Operating Income | -4.60M |
| Pretax Income | -4.62M |
| Net Income | -4.62M |
| EBITDA | n/a |
| EBIT | -4.58M |
| Loss Per Share | -$0.37 |
Balance Sheet
The company has $943,797 in cash and $175,779 in debt, giving a net cash position of $768,018 or $0.04 per share.
| Cash & Cash Equivalents | 943,797 |
| Total Debt | 175,779 |
| Net Cash | 768,018 |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 2.49M |
| Book Value Per Share | 0.13 |
| Working Capital | 1.92M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 67.84%, with operating and profit margins of -210.45% and -211.42%.
| Gross Margin | 67.84% |
| Operating Margin | -210.45% |
| Pretax Margin | -211.42% |
| Profit Margin | -211.42% |
| EBITDA Margin | n/a |
| EBIT Margin | -209.57% |
| FCF Margin | n/a |
Dividends & Yields
Elevai Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.52% |
| Shareholder Yield | -78.52% |
| Earnings Yield | -42.74% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Elevai Labs has an Altman Z-Score of -1.58 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.58 |
| Piotroski F-Score | 1 |